Navidea To Issue Dual Listing On TASE

August 25, 2015 | Navidea Biopharmaceuticals announced that it would register its shares in a dual listing on the Tel Aviv Stock Exchange (TASE). The biopharmaceutical company that produces precision diagnostics, therapeutics and radiopharmaceutical agents is already listed on the New York Stock Exchange. Dual listing on the TASE is allowed in the United States and Israel without any additional regulatory requirements. Navidea Biopharmaceuticals is headquartered in Ohio.